Hannah Brown | Profiles RNS

Hannah E. Brown, MD

Assistant Professor

Boston University Chobanian & Avedisian School of Medicine

Psychiatry

MD, Harvard Medical School
BA, Barnard College

Websites

	BMC
	WRAP's Research Program
	ResearchGate
	Massachusetts General Hospital
	BUSM
	BU Psychiatry

Hannah Brown, MD is the Director of the Wellness and Recovery After Psychosis (WRAP) clinical and research programs, Vice Chair of Research of the Division of Psychiatry at BMC, and Assistant Professor of Psychiatry at Chobanian and Avedisian School of Medicine.

She earned her MD from Harvard Medical School, completed residency training in adult psychiatry, and completed a Fellowship in Schizophrenia at Massachusetts General Hospital. She is a recipient of a 2013 NARSAD Young Investigator Grant, the American Psychological Association Early Academic Career Award on Schizophrenia Research, and the 2014 Dupont-Warren Fellowship awarded through Harvard Department of Psychiatry.

She has served as principal investigator for multiple clinical and translational research studies across MGH and BMC. She has published over 30 peer reviewed articles, book chapters, and invited commentaries on schizophrenia. She has mentored multiple medical students, residents, fellows, and early faculty members, including K award and other grant recipients. She is the recipient of the 2021 Excellence in Mentorship Award from the Department of Psychiatry at BMC.

Vice Chair of Research
Boston Medical Center
Psychiatry

BMC Research

CT-155-R-001
07/28/2023 - 07/27/2026 (PI)
Click Therapeutics Inc.

First Episode Psychosis Program - Staff Enhancement and Evidence Based Practice Implementation Grants
03/01/2022 - 06/30/2024 (PI)
Massachusetts Department of Mental Health/DMH Substance Abuse and

Comparative effectiveness of cognitive enhancement therapy vs. social skills training in serious mental illness (SMI)
02/01/2023 - 01/31/2024 (PI)
Beth Israel Deaconess Medical Center Patient-Centered Out

Laboratory for Early Psychosis Research (LEAP)
09/01/2019 - 06/30/2023 (PI)
McLean Hospital National Institute o

Livingston Award
07/01/2021 - 12/31/2022 (PI)
Massachusetts General Hospital Harvard Medical Scho

Project RISE- First Episode Psychosis Program
11/01/2018 - 09/30/2021 (PI)
DMH

Title

Yr	Title	Project-Sub Proj	Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Gouse BM, Schwarz AG, Gibbs JS, Weinberg JM, Yue H, Chava A, Brown HE. Demographic predictors of lack of current mental health treatment among university students with a schizophrenia spectrum disorder. Early Interv Psychiatry. 2023 Apr 20.View Related Profiles.

Gouse, Brittany
Brown, Hannah
Weinberg, Janice

PMID: 37081818; DOI: 10.1111/eip.13422;

Gouse BM, Boliver EE, Oblath R, Camacho L, Brown HE. Cannabis use among patients presenting to the emergency department for psychosis: Associations with restraint use, medication administration, psychiatric hospitalization, and repeat visits. Psychiatry Res. 2023 May; 323:115151.View Related Profiles.

Gouse, Brittany
Brown, Hannah
Oblath, Rachel

PMID: 36934468

Gouse, Brittany
Brown, Hannah

PMID: 36934468

Brown H, Ongur D, Smurawska L, Valcourt S. Inpatient - Outpatient transitions in first episode psychosis care. Schizophr Res. 2022 Dec; 250:123-124. PMID: 36401993; PMCID: PMC9742132; DOI: 10.1016/j.schres.2022.10.014;

Gouse BM, Brown HE. Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness. JAMA Netw Open. 2022 Jul 01; 5(7):e2224172.View Related Profiles.

Gouse, Brittany
Brown, Hannah

PMID: 35900769

Schor SH, Gibbs JS, Gouse BM, Brown HE. A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts. Schizophr Res. 2022 Aug; 246:63-64.View Related Profiles.

Gouse, Brittany
Brown, Hannah

PMID: 35716577; PMCID: PMC9167853; DOI: 10.1016/j.schres.2022.06.002;

Gibbs JS, Kriegsman S, Brown HE. Dismantling Racial Inequities in Early Psychosis Family Psychoeducation. Psychiatr Serv. 2022 Sep 01; 73(9):1065-1068. PMID: 35291816

Tseng CJ, Gilbert TM, Catanese MC, Hightower BG, Peters AT, Parmar AJ, Kim M, Wang C, Roffman JL, Brown HE, Perlis RH, Zürcher NR, Hooker JM. In vivo human brain expression of histone deacetylases in bipolar disorder. Transl Psychiatry. 2020 07 08; 10(1):224. PMID: 32641695; PMCID: PMC7343804; DOI: 10.1038/s41398-020-00911-5;

Brown HE, Feinstein S, Henderson DC. Working With Patients With Impaired Insight. JAMA Psychiatry. 2020 07 01; 77(7):766-767.View Related Profiles.

Henderson, David
Brown, Hannah

PMID: 32347904

Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown H, Evins AE, Donovan A. Developing a Sound Body: Open Trial Results of a Group Healthy Lifestyle Intervention for Young Adults with Psychosis. Community Ment Health J. 2021 07; 57(5):864-871. PMID: 32524260

Showing 10 of 22 results. Show More

Sonabend W A, Pellegrini AM, Chan S, Brown HE, Rosenquist JN, Vuijk PJ, Doyle AE, Perlis RH, Cai T. Integrating questionnaire measures for transdiagnostic psychiatric phenotyping using word2vec. PLoS One. 2020; 15(4):e0230663. PMID: 32243452; PMCID: PMC7122719; DOI: 10.1371/journal.pone.0230663;

Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH. Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry. 2019 07 01; 76(7):691-699. PMID: 30916714; PMCID: PMC6583662; DOI: 10.1001/jamapsychiatry.2019.0151;

Sellgren CM, Gracias J, Watmuff B, Biag JD, Thanos JM, Whittredge PB, Fu T, Worringer K, Brown HE, Wang J, Kaykas A, Karmacharya R, Goold CP, Sheridan SD, Perlis RH. Increased synapse elimination by microglia in schizophrenia patient-derived models of synaptic pruning. Nat Neurosci. 2019 03; 22(3):374-385. PMID: 30718903; PMCID: PMC6410571; DOI: 10.1038/s41593-018-0334-7;

Hart KL, Brown HE, Roffman JL, Perlis RH. Risk tolerance measured by probability discounting among individuals with primary mood and psychotic disorders. Neuropsychology. 2019 Mar; 33(3):417-424. PMID: 30688494; PMCID: PMC10034864; DOI: 10.1037/neu0000506;

Gilbert TM, Zürcher NR, Wu CJ, Bhanot A, Hightower BG, Kim M, Albrecht DS, Wey HY, Schroeder FA, Rodriguez-Thompson A, Morin TM, Hart KL, Pellegrini AM, Riley MM, Wang C, Stufflebeam SM, Haggarty SJ, Holt DJ, Loggia ML, Perlis RH, Brown HE, Roffman JL, Hooker JM. PET neuroimaging reveals histone deacetylase dysregulation in schizophrenia. J Clin Invest. 2019 01 02; 129(1):364-372.View Related Profiles.

Bhanot, Anisha
Brown, Hannah

PMID: 30530989; PMCID: PMC6307962; DOI: 10.1172/JCI123743;

Brown HE. Identifying Risk of Psychosis in a Primary Care Setting. JAMA Netw Open. 2018 11 02; 1(7):e185165. PMID: 30646386; DOI: 10.1001/jamanetworkopen.2018.5165;

Brown HE, Hart KL, Snapper LA, Roffman JL, Perlis RH. Impairment in delay discounting in schizophrenia and schizoaffective disorder but not primary mood disorders. NPJ Schizophr. 2018 May 28; 4(1):9. PMID: 29808011; PMCID: PMC5972152; DOI: 10.1038/s41537-018-0050-z;

McCoy TH, Yu S, Hart KL, Castro VM, Brown HE, Rosenquist JN, Doyle AE, Vuijk PJ, Cai T, Perlis RH. High Throughput Phenotyping for Dimensional Psychopathology in Electronic Health Records. Biol Psychiatry. 2018 06 15; 83(12):997-1004. PMID: 29496195; PMCID: PMC5972065; DOI: 10.1016/j.biopsych.2018.01.011;

Brown HE, Roffman JL. Emerging Treatments in Schizophrenia: Highlights from Recent Supplementation and Prevention Trials. Harv Rev Psychiatry. 2016 Mar-Apr; 24(2):e1-7. PMID: 26954600; DOI: 10.1097/HRP.0000000000000101;

Brown HE, Roffman JL. Vitamin supplementation in the treatment of schizophrenia. CNS Drugs. 2014 Jul; 28(7):611-22. PMID: 24846474; PMCID: PMC4083629; DOI: 10.1007/s40263-014-0172-4;

Brown HE, Stoklosa J, Freundenriech O. Current Psychiatry. How to stabilize an acutely psychotic patient. 2012; 11(12):10-16.

Brown HE, Flaherty AW, Goff DC, Freudenreich O. A case of dramatic improvement of severe tardive dyskinesia after switch to aripiprazole. Prim Care Companion CNS Disord. 2011; 13(6). PMID: 22454797; PMCID: PMC3304679; DOI: 10.4088/PCC.11l01188;

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 21 publications over 9 distinct years, with a maximum of 4 publications in 2018 and 2020 and 2022

Bar chart showing 21 publications over 9 distinct years, with a maximum of 4 publications in 2018 and 2020 and 2022

Year	Publications
2011	1
2012	1
2014	1
2016	1
2018	4
2019	3
2020	4
2022	4
2023	2

Media Mentions

Boston Top Docs: Hannah Brown

Boston Magazine 1/1/2023

3 people share how they lived through the pandemic with a serious mental illness

NPR 5/30/2022

Interesting People Doing Important Work: Hannah Brown, MD

Mary Christie Institute 4/14/2021

Adjunctive IV Nitroprusside Of No Value In Treatment-Resistant Schizophrenia

Reuters Health 4/3/2019

2021 Boston Medical Center: Excellence in Mentorship, Department of Psychiatry

2020 Boston University School of Medicine: James T. Chengelis Humanism Award, Boston Medical Center Psychiatry Residency

2014 American Psychiatric Foundation: Early Academic Career Award

2014 University of Pittsburgh/Stanford University: Selected for Psychiatric Research Career Development Institute

2013 NARSAD Young Investigator Grant

2008 Harvard Medical School: Gerald S. Foster Award

2006 Soma Weiss Research Day: Select Presenter

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Schizophrenia
Psychosis
Psychiatric Research
Clinical Trials

Available to Mentor as: (Review Mentor Role Definitions):